Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/12897
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorFREITAS, Sarah Cristina Ferreira-
dc.contributor.authorHARTHMANN, Angela d'Avila-
dc.contributor.authorRODRIGUES, Bruno-
dc.contributor.authorIRIGOYEN, Maria-Claudia-
dc.contributor.authorANGELIS, Katia De-
dc.date.accessioned2016-02-11T14:20:21Z-
dc.date.available2016-02-11T14:20:21Z-
dc.date.issued2015-
dc.identifier.citationDIABETOLOGY & METABOLIC SYNDROME, v.7, article ID 115, 8p, 2015-
dc.identifier.issn1758-5996-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/12897-
dc.description.abstractBackground: Hyperglycemia has been associated with decreased blood flow in various organs, leading to tissue damage and dysfunctions. Exercise training (ET) is known to promote beneficial changes in the autonomic nervous system and may have effects on circulation. The aim of this study was to evaluate coronary and renal blood flows and vascular resistances after ET in diabetic rats. Methods: Thirty-two rats were divided into four groups (n = 8): sedentary control (SC), trained control (TC), sedentary diabetic (SD), trained diabetic (TD). Diabetes was induced by an injection of streptozotocin (STZ, 50 mg/kg). The ET was performed on a treadmill for 10 weeks. The blood flows were measured using colored microspheres. Results: The diabetic groups presented hyperglycemia (blood glucose >350 mg/dL) and ET did not change this parameter. The SD group showed reduced renal blood flow when compared to SC group, and ET was able to normalize this parameter in TD rats (SC: 4.3 +/- 0.5; TC: 2.9 +/- 0.3; SD: 1.9 +/- 0.4; TD: 3.2 +/- 0.4 mL/min/g). TD group presented increased coronary blood flow in relation to SD group (SC: 2.3 +/- 0.23; TC: 2.8 +/- 0.5; SD: 1.2 +/- 0.4; TD: 3.0 +/- 0.4 mL/min/g). The heart and kidneys vascular resistance were increased in SD group when compared to SC group, and ET was able to reverse these changes. Conclusions: Given the relevance of cardiomyopathy and nephropathy in mortality of diabetics, our results demonstrated that ET is effective in improving coronary and renal blood flows and vascular resistances in STZ-diabetic rats, reinforcing the positive role of this approach in preventing hyperglycemia-induced long-term organ damage.-
dc.description.sponsorshipCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-PROSUP) [88881.062178/2014-01]-
dc.description.sponsorshipSao Paulo Research Foundation (FAPESP) [2012/20141-5, 2007/52419-4]-
dc.description.sponsorshipCNPq [563961/2010-4, 457200/2014-6]-
dc.description.sponsorshipCNPq-BPQ fellowships-
dc.language.isoeng-
dc.publisherBIOMED CENTRAL LTD-
dc.relation.ispartofDiabetology & Metabolic Syndrome-
dc.rightsopenAccess-
dc.subjectRegional blood flow-
dc.subjectExercise training-
dc.subjectStreptozotocin rats-
dc.subjectDiabetes-
dc.subject.othernitric-oxide-
dc.subject.otherarterial-pressure-
dc.subject.otherangiotensin-ii-
dc.subject.othercardiac-output-
dc.subject.otherdysfunction-
dc.subject.othermicrospheres-
dc.subject.otherhemodynamics-
dc.subject.otherbaroreflex-
dc.subject.othermellitus-
dc.subject.otherliver-
dc.titleEffect of aerobic exercise training on regional blood flow and vascular resistance in diabetic rats-
dc.typearticle-
dc.rights.holderCopyright BIOMED CENTRAL LTD-
dc.identifier.doi10.1186/s13098-015-0109-1-
dc.identifier.pmid26697119-
dc.subject.wosEndocrinology & Metabolism-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalFREITAS, Sarah Cristina Ferreira:Univ Nove Julho, Translat Physiol Lab, BR-01504001 Sao Paulo, SP, Brazil-
hcfmusp.author.externalHARTHMANN, Angela d'Avila:Univ Sao Paulo, Sch Med, Hypertens Unit, Heart Inst InCor, Sao Paulo, Brazil-
hcfmusp.author.externalRODRIGUES, Bruno:Univ Campinas UNICAMP, Fac Phys Educ FEF, Dept Adapted Phys Educ, Campinas, SP, Brazil-
hcfmusp.author.externalANGELIS, Katia De:Univ Nove Julho, Translat Physiol Lab, BR-01504001 Sao Paulo, SP, Brazil-
hcfmusp.description.articlenumber115-
hcfmusp.description.volume7-
hcfmusp.origemWOS-
hcfmusp.origem.idWOS:000366888700002-
hcfmusp.origem.id2-s2.0-84955328739-
hcfmusp.publisher.cityLONDON-
hcfmusp.publisher.countryENGLAND-
hcfmusp.relation.referenceAkbarzadeh A, 2007, Indian J Clin Biochem, V22, P60, DOI 10.1007/BF02913315-
hcfmusp.relation.referenceAmiya Eisuke, 2014, Ann Vasc Dis, V7, P109, DOI 10.3400/avd.ra.14-00048-
hcfmusp.relation.referenceNakanishi K, 2005, METABOLISM, V54, P788, DOI 10.1016/j.metabol.2005.01.023-
hcfmusp.relation.referenceAndersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571-
hcfmusp.relation.referenceLima TI, 2015, LIFE SCI, V128, P64, DOI 10.1016/j.lfs.2015.01.031-
hcfmusp.relation.referenceSridulyakul P, 2003, CLIN HEMORHEOL MICRO, V29, P423-
hcfmusp.relation.reference[Anonymous], 1995, KIDNEY INT, V47, P1703-
hcfmusp.relation.referenceDe Angelis K, 2005, BRAZ J MED BIOL RES, V38, P119, DOI 10.1590/S0100-879X2005000100018-
hcfmusp.relation.referenceD'Amico M, 2001, DIABETOLOGIA, V44, P464, DOI 10.1007/s001250051644-
hcfmusp.relation.referenceHAKKINEN JP, 1995, CARDIOVASC RES, V29, P74, DOI 10.1016/S0008-6363(96)88549-X-
hcfmusp.relation.referenceGreen DJ, 2014, HYPERTENSION, V63, P376, DOI 10.1161/HYPERTENSIONAHA.113.02044-
hcfmusp.relation.referenceLam DW, 2012, CURR OPIN ENDOCRINOL, V19, P93, DOI 10.1097/MED.0b013e328350583a-
hcfmusp.relation.referenceSchnell O, 2001, DIABETES METAB RES, V17, P243, DOI 10.1002/dmrr.220.abs-
hcfmusp.relation.referenceKing GL, 1996, ANN MED, V28, P427, DOI 10.3109/07853899608999103-
hcfmusp.relation.referenceJACKSON CV, 1983, J CARDIOVASC PHARM, V5, P260, DOI 10.1097/00005344-198303000-00016-
hcfmusp.relation.referenceDe Angelis KLD, 2000, BRAZ J MED BIOL RES, V33, P635-
hcfmusp.relation.referenceToda N, 2010, PHARMACOL THERAPEUT, V127, P189, DOI 10.1016/j.pharmthera.2010.04.009-
hcfmusp.relation.referenceIrigoyen MC, 2005, HYPERTENSION, V46, P998, DOI 10.1161/01.HYP.0000176238.90688.6b-
hcfmusp.relation.referenceBrands MW, 2003, AM J HYPERTENS, V16, P600, DOI 10.1016/S0895-7061(03)00902-6-
hcfmusp.relation.referenceHEYMANN MA, 1977, PROG CARDIOVASC DIS, V20, P55, DOI 10.1016/S0033-0620(77)80005-4-
hcfmusp.relation.referenceHILL MA, 1989, AM J PHYSIOL, V257, pH571-
hcfmusp.relation.referenceMcAllister RM, 1998, MED SCI SPORT EXER, V30, P375, DOI 10.1097/00005768-199803000-00006-
hcfmusp.relation.referenceVinik AI, 2011, DIABETIC MED, V28, P643, DOI 10.1111/j.1464-5491.2010.03184.x-
hcfmusp.relation.referenceBlack MA, 2009, AM J PHYSIOL-HEART C, V297, pH1109, DOI 10.1152/ajpheart.00226.2009-
hcfmusp.relation.referenceHeyman SN, 2013, BIOMED RES INT, DOI 10.1155/2013/123589-
hcfmusp.relation.referenceDEBLIEUX PMC, 1993, P SOC EXP BIOL MED, V203, P209-
hcfmusp.relation.referenceHOSTETTER TH, 1981, KIDNEY INT, V19, P410, DOI 10.1038/ki.1981.33-
hcfmusp.relation.referenceGUYTON AC, 1981, CIRCULATION, V64, P1079-
hcfmusp.relation.referenceLash JM, 1998, MED SCI SPORT EXER, V30, P60, DOI 10.1097/00005768-199801000-00009-
hcfmusp.relation.referenceQuinteiro H, 2015, MENOPAUSE, V22, P534, DOI [10.1097/GME.0000000000000344, 10.1097/gme.0000000000000344]-
hcfmusp.relation.referenceLavoie JM, 2002, CAN J PHYSIOL PHARM, V80, P1035, DOI 10.1139/Y02-137-
hcfmusp.relation.referenceHarthmann AD, 2007, AUTON NEUROSCI-BASIC, V133, P115, DOI 10.1016/j.autneu.2006.10.004-
hcfmusp.relation.referenceLAUGHLIN MH, 1995, MED SCI SPORT EXER, V27, P1135-
hcfmusp.relation.referencePUGLIESE G, 1989, DIABETOLOGIA, V32, P845, DOI 10.1007/BF00297449-
hcfmusp.relation.referenceMaser RE, 2013, DIABETES OBES METAB, V15, P28, DOI 10.1111/j.1463-1326.2012.01669.x-
hcfmusp.relation.referenced'Avila KDL, 1999, HYPERTENSION, V34, P768-
hcfmusp.relation.referencedos Santos Silva KA, 2012, PLOS ONE, V7-
hcfmusp.relation.referenceMelendez-Ramirez LY, 2010, ENDOCRIN METAB CLIN, V39, P625, DOI 10.1016/j.ecl.2010.05.009-
hcfmusp.relation.referenceMorrish NJ, 2001, DIABETOLOGIA S, V44, P2-
hcfmusp.relation.referenceRodrigues B, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-38-
hcfmusp.relation.referenceVerrotti Alberto, 2014, Front Endocrinol (Lausanne), V5, P205, DOI 10.3389/fendo.2014.00205-
hcfmusp.relation.referenceWichi R, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-14-
dc.description.indexPubMed-
hcfmusp.citation.scopus2-
hcfmusp.scopus.lastupdate2024-03-08-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HC/InCor
Instituto do Coração - HC/InCor

Artigos e Materiais de Revistas Científicas - LIM/59
LIM/59 - Laboratório de Biologia Celular

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_FREITAS_Effect_of_aerobic_exercise_training_on_regional_blood_2015.PDFpublishedVersion (English)901.44 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.